Western blotting results indicated that HYAL2 knockdown induced Bcl-2 downregulation, an anti-apoptotic protein, in glioma cells; more importantly, HYAL2 silencing increased the level of BAX, a pro-apoptotic protein, in glioma cells (Fig. 6F). Here, BCL2 is linked to central nervous system cancer.